Ocean Biomedical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ocean Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2021 to Q1 2024.
  • Ocean Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $13M.
  • Ocean Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$29.4M, a 65.1% increase year-over-year.
  • Ocean Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$114M, a 559% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $13M +$85.1M Mar 31, 2024 10-Q 2024-12-23
Q4 2023 -$16.9M -$15.9M -1615% Dec 31, 2023 10-K 2024-11-25
Q3 2023 -$14.1M -$10.4M -284% Sep 30, 2023 10-Q 2024-04-15
Q2 2023 -$11.4M -$4.1M -55.9% Jun 30, 2023 10-Q/A 2024-04-15
Q1 2023 -$72.1M -$66.7M -1241% Mar 31, 2023 10-Q 2024-12-23
Q4 2022 -$983K Dec 31, 2022 10-K 2024-11-25
Q3 2022 -$3.67M -$3.63M -8521% Sep 30, 2022 10-Q 2024-04-15
Q2 2022 -$7.33M -$7.33M Jun 30, 2022 10-Q/A 2024-04-15
Q1 2022 -$5.38M Mar 31, 2022 10-Q/A 2024-04-15
Q3 2021 -$42.5K Sep 30, 2021 10-Q 2022-10-17
Q2 2021 -$82* Jun 30, 2021 10-Q 2022-10-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.